Trial
NCT03726398
CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Franz Rischard, DO
Collaborators
National Jewish Health; University of Pittsburgh
Condition
Interstitial Lung Disease
Intervention
Opsumit 10 Mg Tablet
Why stopped
Did not identify eligible candidates
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-20